Duty to Manufacture Sample Clauses

Duty to Manufacture. Apollo shall (a) establish and thereafter maintain sufficient manufacturing capacity to produce the Company Products in quantities sufficient to fill the Company's projected monthly requirement set forth by the Company; (b) use its reasonable efforts to maintain a sufficient level of inventory of the Company Products to fulfill the Company's purchase orders; (c) upon discussions with the Company, buy all raw materials and parts necessary to manufacture such quantities of the Company Products; and (d) upon discussions with the Company, purchase and fabricate any molds, patterns and tooling necessary to manufacture the Company Products.
AutoNDA by SimpleDocs
Duty to Manufacture. Notwithstanding any expiration or termination of this Agreement (other than termination by the Supplier pursuant to Section 8.2 or 8.3 hereof), the Supplier shall manufacture, fulfill and ship all Products ordered by AMO and its Affiliates prior to the date of expiration or termination of this Agreement.
Duty to Manufacture. 10 5.6 Inventory Support .................................... 10 5.7
Duty to Manufacture. ORTHOBIO shall establish and maintain the capacity necessary to produce in any thirty (30)-day period a quantity of the Products sufficient to satisfy the greater of (a) twelve percent (12%) of MENTOR's Agreed Purchase Commitment for the Products for the then-current Computation Period or (b) ten percent (10%) of MENTOR's actual purchases during the preceding calendar year. MENTOR's Firm Order pursuant to Section 5.7, below, for any given month shall not exceed ORTHOBIO's then-existing production capacity unless ORTHOBIO agrees otherwise.
Duty to Manufacture. NAMS shall establish and maintain sufficient capacity necessary to satisfy MENTOR's Anticipated Requirements for the Product during the first and second Sales Years and thereafter shall increase its production capacity to the extent that the parties mutually agree or, in the absence of an agreement to the contrary, to an amount sufficient to satisfy MENTOR's requirements if MENTOR's sales were to increase each year by the percentage increase, if any, in its sales in the preceding year.
Duty to Manufacture. RHINO shall: (a) establish and thereafter maintain sufficient manufacturing capacity to produce RT/RREVs in quantities sufficient to fill RRV’s projected periodic requirements, as set forth in RRV’s periodic Forecasts; provided, however, that such Forecasts do not exceed twenty percent (20%) of the immediately preceding Forecast delivered to RHINO; provided, further, however, that RHINO shall not be required to acquire additional facilities, plants or equipment to carry out the Forecasts if and when such Forecasts increase in quantity; (b) use its reasonable efforts to maintain a sufficient level of inventory of the RT/RREVs (and/or the component parts necessary) to fulfill RRV’s purchase orders consistent with the Forecast; (c) at its expense, buy all raw materials and component parts necessary to manufacture, fabricate and/or assemble such quantities of the RT/RREVs to fulfill RRV’s Purchase Orders; and (d) purchase, manufacture, assemble and/or fabricate at its 1 For example, but not by way of limitation, if RHINO terminated this Agreement effective December 31, 2011, and RRV had purchased the number of RT/RREVs shown in the Table in §2.5, then each Party’s outstanding, unrecouped “Development Cost Amount” would be the sum of $100,000, determined as follows: The amount of the Development Cost Amount on the date of this Agreement [i.e., $250,000], LESS an amount equal to $1,000 TIMES the number of RT/RREVs purchased by RRV in the initial Term [i.e., 10 x $1,000 + $10,000], the First Renewal Term [i.e., 20 x $1,000 + $20,000], the Second Renewal Term [i.e., 40 x $1,000 + $40,000], and the Third Renewal Term [i.e., 80 x $1,000 + $80,000] – all for a total of $150,000.) expense any dies, jigs, molds, patterns and tools necessary to manufacture, assemble and/or fabricate at its expense the RT/RREVs.
Duty to Manufacture. Upon completion of the Pre-Manufacturing Phase, NASI agrees to take responsibility for the ion implantation facility and to manufacture Products to mutually agreed upon Product Specifications and in accordance with forecasts provided by RADIOMED pursuant to Section 4.6 hereof. NASI agrees to provide access to the ion implantation facility by RADIOMED personnel for research and development activities, provided that such access does not interfere with scheduled manufacturing activities.
AutoNDA by SimpleDocs

Related to Duty to Manufacture

  • Marking of Licensed Products To the extent commercially feasible and consistent with prevailing business practices, Company shall xxxx, and shall cause its Affiliates and Sublicensees to xxxx, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.

  • Supply of Materials Unless the parties otherwise agree in a Work Order, Manufacturer will supply, in accordance with the relevant approved raw material specifications, all materials to be used by Manufacturer in the performance of Services under a Work Order other than the Rhythm Materials specified in such Work Order. Rhythm or its designees will provide Manufacturer with the Rhythm Materials. Manufacturer agrees (a) to account for all Rhythm Materials, (b) not to provide Rhythm Materials to any third party (other than an Affiliate acting as a permitted subcontractor) without the express prior written consent of Rhythm, (c) not to use Rhythm Materials for any purpose other than conducting the Services, including, without limitation, not to analyze, characterize, modify or reverse engineer any Rhythm Materials or take any action to determine the structure or composition of any Rhythm Materials unless required * CONFIDENTIAL TREATMENT REQUESTED. OMITTED PORTIONS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. pursuant to a signed Work Order, and (d) to destroy or return to Rhythm all unused quantities of Rhythm Materials according to Rhythm’s written directions.

  • Licensed Technology The term "Licensed Technology" shall mean the ------------------- Licensed Patents, plus all improvements thereto developed by Licensor, and all related data, know-how and technology.

  • Technical Information Methods, processes, formulae, compositions, systems, techniques, inventions, machines, computer programs and research projects, unpatented inventions, designs, know-how, trade secrets, technical information and data, specifications, blueprints, transparencies, test data, and additions, modifications, and improvements thereon which are revealed to Employee.

  • Review of Materials During the term of this Agreement, Client shall ensure that all prospectuses, statements of additional information, registration statements, proxy statements, reports to shareholders, advertising and sales literature or other materials prepared for distribution to Fund shareholders or the public, which refer to the Subadviser in any way, prepared by employees or agents of Client or its affiliates are consistent with information previously provided by Subadviser. Subadviser shall promptly notify the Client of any changes to information pertaining to the Subadviser and stated in the materials described in this Section 6(g).

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • No Improper Use of Materials During his or her employment with the Company, Employee will not improperly use or disclose any Confidential Information or trade secrets, if any, of any former employer or any other person to whom Employee has an obligation of confidentiality, and Employee will not bring onto the premises of the Company any unpublished documents or any property belonging to any former employer or any other person to whom Employee has an obligation of confidentiality unless consented to in writing by that former employer or person.

  • Third Party Technology The assignment of any applicable license agreements with respect to Third Party Technology are set forth in the General Assignment and Assumption Agreement.

  • Manufacture (a) Manufacturer shall only manufacture the specific number of Products as requested by Company and at no time shall manufacture excess goods or overruns. Manufacturer shall not sell any Products bearing the Trademarks to any third parties without the express written consent of Company.

  • Licensed Patents Immune Design, at its expense, shall have the first right to file, prosecute and maintain all Licensed Patents for which Immune Design has any exclusive rights under this Agreement using patent counsel reasonably approved by IDRI, including conducting any interferences, reexaminations, reissues, oppositions, or request for patent term extension relating thereto. Immune Design shall conduct such filing, prosecution and maintenance in good faith, taking into consideration IDRI’s retained rights hereunder, and consistent with reasonable business judgment, provide IDRI with all relevant or material documentation and proposed filing in the Territory so that IDRI may be concurrently and promptly informed of the continuing prosecution, and consult with IDRI with regards to Immune Design’s patent strategy with the Licensed Patents for which Immune Design has any exclusive rights under this Agreement. Licensed Patents in the name of IDRI shall remain in the name of IDRI. Immune Design shall use commercially reasonable efforts to ***, as applicable. To the extent such ***, Immune Design shall provide IDRI reasonable opportunity to review and comment on such prosecution efforts regarding such Licensed Patents in the Territory, and any IDRI comments will be reasonably considered in such prosecution efforts, and included to the extent affecting the IDRI Exclusive Field or IDRI Territory, as the case may be. If Immune Design determines in its sole discretion to abandon or not maintain any Licensed Patent for which Immune Design has any exclusive rights under this Agreement in the Territory, then Immune Design shall promptly provide IDRI with written notice of such determination at least sixty (60) days before any deadline for taking action to avoid abandonment and shall provide IDRI with the right, opportunity and reasonable assistance to prepare, file, prosecute and maintain such Licensed Patent in the applicable jurisdiction in IDRI’s sole discretion and at IDRI’s expense, provided that Immune Design shall provide such reasonable assistance at its *** INDICATES MATERIAL THAT WAS OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT WAS REQUESTED. ALL SUCH OMITTED MATERIAL WAS FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. own costs and expenses. If IDRI elects to prepare, file, prosecute and maintain such Licensed Patent in such jurisdiction for which Immune Design has any exclusive rights, then Immune Design’s license rights to such Licensed Patent in such country will become nonexclusive in such country under such Licensed Patent (and/or patent application). If IDRI desires Immune Design to file, in a particular jurisdiction, a Licensed Patent for which Immune Design has any exclusive rights under this Agreement that claims priority to another Licensed Patent for which Immune Design has any exclusive rights under this Agreement, IDRI shall provide written notice to Immune Design requesting that Immune Design file such patent application in such jurisdiction. If IDRI provides such written notice to Immune Design, Immune Design shall either (i) file and prosecute such patent application and maintain any patent issuing thereon in such jurisdiction and the Parties shall share the related costs and expenses (A) in countries *** on the basis of *** percent (***%) Immune Design: *** percent (***%) IDRI or (B) in countries within the IDRI Territory equally; or (ii) notify IDRI that Immune Design does not desire to file such patent application in such jurisdiction and provide IDRI with the opportunity to file and prosecute such patent application, provided that if IDRI files and prosecutes such patent application in such jurisdiction, then Immune Design’s license rights to such License Patent in such country will become nonexclusive in such country under such Licensed GLA Patent (and/or patent application). Immune Design shall be responsible for the costs and expenses incurred in connection with its own activities for filing, prosecuting and maintaining the Licensed Patents; IDRI shall be responsible for monitoring of such activities by IDRI.

Time is Money Join Law Insider Premium to draft better contracts faster.